Results 161 to 170 of about 29,473,219 (216)

Erratum: Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. [PDF]

Mol Ther Methods Clin Dev
Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Abou Haidar E, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, Breakefield XO.   +15 more
europepmc   +1 more source

Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: A Systematic Review of Tumor Control and Hearing Preservation. [PDF]

J Clin Med
Screnci M, Puechmaille M, Berton Q, Khalil T, Mom T, Coll G.   +5 more
europepmc   +1 more source

Neurofibromatosis Type 2 Presenting as Symptomatic Gallbladder Hydrops: A Rare Case Report and Literature Review. [PDF]

Case Rep Pediatr
Hafez B, Alwan JS, El Hout W, Koussa K, El Annan T, Noun D, Zaghal A.   +6 more
europepmc   +1 more source

Presenting characteristics and clinical outcomes of idiopathic versus neurofibromatosis type 2-associated spinal meningiomas: a retrospective institutional experience. [PDF]

J Neurosurg Spine
Nawabi NLA, Chalif JI, Renauld S, Mehta NH, Jha R, Gerstl JVE, Chalif E, Gupta S, Chi JH.   +8 more
europepmc   +1 more source

Retinal Ischemia as a Presenting Ocular Sign of Neurofibromatosis Type 2. [PDF]

Case Rep Ophthalmol Med
Zhao B, Yan Y.
europepmc   +1 more source

Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions. [PDF]

Oncol Ther
Yuan R, Wang B, Wang Y, Liu P.
europepmc   +1 more source

Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2. [PDF]

Laryngoscope
Seo S, Shen S, Ding AS, Creighton FX.
europepmc   +1 more source

Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials. [PDF]

Clin Trials
Thompson HL, Grabowski J, Franklin B, Koetsier KS, Welling DB.   +4 more
europepmc   +1 more source

[Type 2 neurofibromatosis].

Gaceta medica de Mexico, 2004
Raúl, Carrillo-Esper, Alejandro, Cruz Suárez Mendoza, Benjamín, Calvo-Carrillo, Mauricio, Paredes-Fernández   +3 more
openaire   +1 more source

Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis. [PDF]

Oncogene
Nagel A, Huegel J, Petrilli A, Rosario R, Victoria B, Hardin HM, Fernandez-Valle C.   +6 more
europepmc   +1 more source